Farmacoeconomía en Oncología

Molina Villaverde, R; Ordóñez Gallego, A; López González, J. L; Redondo Sánchez, A; Andreu Rodríguez, M; González Barón, M.
Oncología (Barc.) ; 24(4): 185-191, abr. 2001. tab
Artículo en Es | IBECS (España) | ID: ibc-15264

Documentos relacionados

  1. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions.
  2. Payment Reform, Medication Use, and Costs: Can We Afford to Leave Out Drugs?
  3. Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.
  4. Deprescription in elderly: A spotlight on pharmacoeconomic aspect.
  5. Subsidy strategy of pharmaceutical e-commerce platform based on two-sided market theory.
  6. [Pharmacoeconomics - Challenges for Health Professionals].
  7. The role of colleges of pharmacy in meeting the pharmacoeconomic needs of the pharmaceutical industry: a conference report.
  8. Distribution and trends in outpatient utilization of generic versus brand name psychopharmaceuticals during a ten-year period in Croatia.
  9. Proposal To Use VA Price As a Benchmark Is off the Mark.
  10. What Was, Is No More: Community Pharmacy Economics.